Advertisement

Topics

Symphogen A/S Company Profile

20:17 EDT 17th June 2018 | BioPortfolio

Symphogen A/S, the biotech company pioneering recombinant human polyclonal antibodies for the treatment and prevention of human disease, today announced the initial closing of a USD 25 million Series D financing at a premium to the last financing round.

Location

Elektrovej Building 375
Lyngby,
DK-2800
Denmark

Contact

Phone: 45 4526 5050
Fax: 45 4526 5060
Email: info@symphogen.com


News Articles [3 Associated News Articles listed on BioPortfolio]

Symphogen Further Strengthens its Immuno-Oncology Pipeline by Advancing into Two Additional Clinical Trials

Symphogen Further Strengthens its Immuno-Oncology Pipeline by Advancing into Two Additional Clinical Trials Seventh Program to enter Clinical Development at Symphogen Symphogen’s antibody platfo...

Symphogen AS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 19022018] Prices from USD $250

SummarySymphogen A/S Symphogen is a biopharmaceutical company that specializes in the field of recombinant antibody mixtures for therapeutic use in cancer. The company focuses on developing superior m...

Colorectal Cancer: Update Bulletin 1 [Report Updated: 01122017] Prices from USD $1095

This edition presents the views and insights from three world leading key opinion leaders KOLs from North America and Europe on a variety of recent events in the colorectal cancer CRC market, includin...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Symphogen

Symphogen is developing superior antibody therapeutics (monoclonal, monoclonal mixtures and polyclonal) to help people with serious diseases and significant unmet medical needs. W...

Symphogen A/S

Symphogen A/S, the biotech company pioneering recombinant human polyclonal antibodies for the treatment and prevention of human disease, today announced the initial closing of a USD 25 million Series ...

More Information about "Symphogen A/S" on BioPortfolio

We have published hundreds of Symphogen A/S news stories on BioPortfolio along with dozens of Symphogen A/S Clinical Trials and PubMed Articles about Symphogen A/S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Symphogen A/S Companies in our database. You can also find out about relevant Symphogen A/S Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record